The hydrolysis of 4-nitrophenyl esters of hexanoate (NphOHe) and decanoate (NphODe) by human serum albumin (HSA) at Tyr411, located at the FA3-FA4 site, has been investigated between pH 5.8 and 9. moreover, the deacylation step turns out to be the rate limiting step in catalysis (i.e., k +3 << k +2 ). The pH dependence of the kinetic parameters for the hydrolysis of NphOHe and NphODe can be described by the acidic pK a -shift of a single amino acid residue, which varies from 8.9 in the free HSA to 7.6 and 7.0 in the HSA:NphOHe and HSA:NphODe complex, respectively; the pK> a -shift appears to be correlated to the length of the fatty acid tail of the substrate. The inhibition of the HSA-Tyr411-catalyzed hydrolysis of NphOHe, NphODe, and 4-nitrophenyl myristate (NphOMy) by five inhibitors (i.e., diazepam, diflunisal, ibuprofen, 3-indoxyl-sulfate, and propofol) has been investigated at pH 7.5 and 22.0°C, resulting competitive. The affinity of diazepam, diflunisal, ibuprofen, 3-indoxyl-sulfate, and propofol for HSA reflects the selectivity of the FA3-FA4 cleft. Under conditions where Tyr411 is not acylated, the molar fraction of diazepam, diflunisal, ibuprofen, and 3-indoxylsulfate bound to HSA is higher than 0.9 whereas the molar fraction of propofol bound to HSA is ca. 0.5.
Introduction
The (pseudo-)enzymatic activity of human serum albumin (HSA) was first reported in 1951 and investigated extensively for decades. Among others, HSA displays esterase, RNA-hydrolyzing, enolase, glucuronidase, lipid peroxidase, aldolase glutathione-linked thiol peroxidase, and anti-oxidant activities. Moreover, heme binding confers to HSA globin-like (pseudo-)enzymatic properties, including detoxification of reactive nitrogen and oxygen species as well as catalase and peroxidase activities. Remarkably, HSA(-heme) (pseudo-)enzymatic properties are modulated allosterically and inhibited competitively [1, 2] .
Although the physiological importance of the esterase activity of HSA is obscure and the natural substrates are still unknown, HSA displays esterase activity towards several substrates including 4-nitrophenyl acetate (NphOAc), α-naphthyl acetate, phenyl acetate, 1-naphthyl Nmethylcarbamate, β-naphthyl acetate, aspirin, ketoprofen glucuronide, carprofen acylglucuronide, cyclophosphamide, nicotinate esters, long and short-chain FA esters (e.g., 4-nitrophenyl myristate; NphOMy), octanoyl ghrelin, organophosphorus pesticides, carbaryl, 2-nitrotrifluoroacetanilide, 2-nitroacetanilide, and nerve agents [1] [2] [3] .
The Lys199 and Tyr411 residues, placed in the fatty acid (FA) 7 (FA7) and 3-4 (FA3-FA4) site, respectively, are pivotal for the esterase activity of HSA; however, mechanisms for the Lys199-and Tyr411-assisted catalysis are substantially different [1] [2] [3] [4] [5] [6] [7] [8] .
At Lys199, the substrate (e.g., acetylsalicylic acid, trinitrobenzeno-sulfonates, and penicillin) is cleaved in two products; while one product is released, the other one binds covalently to the Lys199 residue [1, 4, 7] . Although the molecular mechanism underlying the Lys199 acetylation is unknown, it seems that its ability to attack the substrate is due to the proximity of the Lys195 residue, these two residues playing a combined and comparable chemical role. In fact, the basic form of Lys199 is likely connected to the acid form of Lys195 through a network of H-bonding water molecules with a donor-acceptor character. The presence of these water bridges is relevant for stabilizing the configuration of the FA7 site and/or promoting a potential Lys195-Lys199 proton-transfer process [6] . Since Lys199 is placed at the entrance of the FA7 site (i.e., Sudlow's site I), ligand binding inhibits the Lys199-dependent esterase activity [3, 8] .
The catalytic mechanism involving the Tyr411 residue appears to be substrate-dependent. Of note, the hydrolysis of the most suitable substrate 4-nitrophenyl propionate leads to the release of both 4-nitrophenol and propionate [9] . This mechanism also applies to the hydrolysis of N-trans-cinnamoylimidazoles [10] and 4-nitrophenil esters of amino acids [11] . However, the Tyr411-assisted hydrolysis of NphOAc and NphOMy leads to the release of 4-nitrophenol and to Tyr411-acetylation and-myristoylation, respectively [12, 13] . The strong nucleophilic nature of the phenolic oxygen of the Tyr411 residue is due to the close proximity of the Arg410 guanidine moiety that electrostatically stabilizes the reactive anionic form of the Tyr411 residue [5, 14] . Since both the Arg410 and Tyr411 residues are placed in the FA3-FA4 site (i.e., Sudlow's site II), ligand binding inhibits the HSA esterase activity [3, 9, 12, 13] . Remarkably, the esterase activity of HSA could play a role in the inactivation of several toxins including organophosphorus compounds [3] .
Present study largely extends previous investigations concerning the hydrolysis of 4-nitrophenyl esters by HSA [9, [12] [13] [14] . In particular, kinetics of the HSA pseudo-enzymatic hydrolysis of 4-nitrophenyl hexanoate (NphOHe) and 4-nitrophenyl decanoate (NphODe) have been investigated between pH 5.8 and 9. . The rationale behind this selection is to investigate how the FA tail length affects the pK a values of the ionizing group that modulates the catalysis. Furthermore, diazepam, diflunisal, ibuprofen, 3-indoxyl-sulfate, and propofol have been reported to inhibit competitively the HSA-Tyr411-catalyzed hydrolysis of NphOHe, NphODe, and 4-nitrophenyl myristate (NphOMy) (see [12] and present study). Remarkably, the molar fraction of diazepam, diflunisal, ibuprofen, and 3-indoxyl-sulfate bound to not acylated HSA is higher than 0.9 whereas the molar fraction of propofol bound to HSA is ca. 0.5.
Materials and Methods
NphOHe, NphODe, NphOMy, 4-nitrophenol (NphOH), diazepam, diflunisal, ibuprofen, 3-indoxyl-sulfate, propofol, and 1,3-bis(tris(hydroxymethyl)methylamino)propane (Bis-tris propane) were obtained from Sigma-Aldrich (St. Louis, MO, USA). All chemicals were of analytical or reagent grade and were used without further purification.
HSA [NphOXx] , were analyzed in the framework of the minimum three step-mechanism reported in Fig. 1 [9, [12] [13] [14] [15] [16] .
Kinetics and thermodynamics of the HSA-Tyr411-catalyzed hydrolysis of NphOHe, NphODe, and NphOMy were also determined in the presence of diazepam, diflunisal, ibuprofen, 3-indoxyl-sulfate and propofol; the ligand concentration ranged between 4.0×10 -6 M and
Kinetic and thermodynamic parameters were obtained between pH 5.8 and 9.5, at 22.0°C. Experiments were carried out with the SFM-200 rapid-mixing stopped-flow apparatus (BioLogic Science Instruments, Claix, France) and the Cary 50 Bio spectrophotometer (Varian Inc., Palo Alto, CA, USA).
Kinetics and thermodynamics of the HSA pseudo-esterase activity were analyzed using the GraphPad Prism program (GraphPad Software, Inc., La Jolla, CA, USA). The results are given as mean values of at least four experiments plus or minus the corresponding standard deviation.
Results

Pseudo-esterase activity of HSA-Tyr411
As previously reported for the HSA-Tyr411-catalyzed hydrolysis of NphOAc and NphOMy [12, 13] , the determination of kinetic parameters of Fig. 1 is simplified by the fact that the formation of the HSA:NphOHe and HSA:NphODe complexes can be treated as a rapid equilibrium process. Indeed, no lag phase occurs in the release of NphOH from NphOHe and NphODe in the presence of HSA (Fig. 2) , indicating that the equilibration of HSA:NphOHe and HSA: NphODe with HSA and NphOHe and NphODe, respectively, is complete within 1.4 ms (i.e., the "dead-time" of the rapid-mixing stopped-flow apparatus). Moreover, the rate of NphOH release from NphOHe and NphODe catalyzed by HSA-Tyr411 is unaffected by the addition of NphOH (up to 1.0×10 -4 M) in the reaction mixtures (data not shown), indicating that the acyl- Table 1 ) were obtained from the hyperbolic plots of k app as a function of the HSA concentration ( Fig. 2 , panels C and D) according to equation (2) [9, 12, 13] :
, the reaction of NphOHe and NphODe with HSA displays a mono-exponential time course (Fig. 2 , panels E and F). Values of the pseudo-first-order rate constant for the HSA-Tyr411-catalyzed hydrolysis of NphOHe and NphODe (i.e., of NphOH release; k obs ) were obtained according to equation (3) [9, 12, 13] : When k +2 ! 5×k +3 , the differential equations arising from Fig. 1 may be solved [12, 13, 16, 17] to describe the time course of NphOH release at the early stages of the reaction. The resulting expression is given in eqs (4)- (6) [12, 13, 16, 17] :
Àk obs Ât ÞÞ þ ððk cat Â ½HSA Â ½NphOXx Â tÞ=ðK m þ ½NphOXxÞÞ ð4Þ Table) , indicating that the HSA: NphOXx:NphOH stoichiometry is 1:1:1. Moreover, the time course of the "burst" phase of NphOH release is a first-order process for more than 95% of its course (Fig. 2, panels E Table 1 ) were determined from hyperbolic plots of k obs versus [NphOXx] (Fig. 2 , panels G and H) according to equation (6) [16, 17] . Under all the experimental conditions, the y-intercept of the hyperbola described by equation (6) was < 2×10 -6 s -1 , thus indicating that the value of k +3 is at least 100-fold smaller than that of k obs obtained at the lowest NphOHe and NphODe concentration (i.e., k +3 < 2×10 -6 s Table 1) . Moreover, data here reported indicate that the deacylation process is rate limiting in the HSA-Tyr411-catalyzed hydrolysis of NphOHe and NphODe, as previously reported for NphOAc and NphOMy [12, 13] (i.e., k +3 << k +2 ). Furthermore, values of K s and k +2 here obtained for the HSA-Tyr411-catalyzed hydrolysis of NphOHe and NphODe agree with those previously reported [9] .
pH effects on the pseudo-esterase activity of HSA-Tyr411
Values of catalytic parameters for the HSA-Tyr411-catalyzed hydrolysis of NphOHe and NphODe obtained between pH 5.8 and 9.5 (at 22.0°C) are summarized in S2 and S3 Tables. Fig. 3 shows the pH dependence of K s , k +2 , and k +2 /K s values for the HSA-Tyr411-catalyzed 
where K s lim , k +2 lim , and (k +2 /K s ) lim are the values corresponding to the alkaline asymptotes of K s , k +2 , and k +2 /K s .
According to linked functions [12, 13, [16] [17] [18] , the pH dependence of K s reflects the acidic pK a -shift of a single amino acid residue from free HSA (i.e., pK unl ) to the HSA:NphOHe and HSA:NphODe complexes (i.e., pK lig ). Moreover, the pH dependence of k +2 and k +2 /K s reflects the acid-base equilibrium of one apparent ionizing group in the HSA:NphOHe and HSA: NphODe complexes (i.e., pK lig ) and in free HSA (i.e., pK unl ), respectively. As expected [12, 13, [16] [17] [18] , the pK a value of free HSA (i.e., pK unl ) is independent of the substrate whereas the pK a values of the HSA:NphOHe and HSA:NphODe complexes (i.e., pK lig ) depend on the substrate (Table 2 ).
Competitive inhibition of the pseudo-esterase activity of HSA-Tyr411
As shown in Fig. 4 , diazepam, diflunisal, ibuprofen, 3-indoxyl-sulfate, and propofol inhibit the Tyr411-catalyzed hydrolysis of NphOHe, NphODe, and NphOMy. As expected for the pure competitive inhibition mechanism [19] , values of K s for the HSA-Tyr411-catalyzed hydrolysis of NphOHe, NphODe, and NphOMy (Fig. 4) allowed to determine the values of the equilibrium dissociation constant for diazepam, diflunisal, ibuprofen, 3-indoxyl-sulfate, and propofol binding to the FA3-FA4 cleft of HSA (i.e., K I , corresponding to the absolute value of the x intercept of the linear plot). As expected for the pure competitive inhibition mechanism [19] , values of K I for diazepam, diflunisal, ibuprofen, 3-indoxyl-sulfate, and/or propofol binding to the FA3-FA4 cleft of HSA are independent of NphOAc [13] , NphOHe (present study), NphODe (present study), and NphOMy (see [12] and present study) (Fig. 5) Inhibition of the Esterase-Like Activity of HSA
Discussion
The hydrolysis of NphOAc, NphOHe, NphODe, and NphOMy by HSA-Tyr411 (see [12] [13] [14] [15] and present study) is reminiscent of that observed for acylating agents with proteases [27] . In fact, NphOAc [13] , NphOHe (present study), NphODe (present study), and NphOMy [12] act as suicide substrates of HSA-Tyr411, values of the deacylation rate constant for all four substrates (i.e., k +3 ) being lower by several orders of magnitude than those of the acylation rate constant (i.e., k +2 ). Remarkably, HSA acylation appears to modulate ligand binding. In fact, HSA acylation by aspirin [28] increases the affinity of phenylbutazone and inhibits bilirubin The PDB ID codes of HSA:diazepam, :diflunisal, :ibuprofen, :3-indoxyl-sulfate, and :propofol complexes are 2BXE, 2BXF, 2BXG, 2BXH, and 1E7A, respectively [8, 30] . The pictures were drawn with the UCSF-Chimera package [46] . For details, see text.
doi:10.1371/journal.pone.0120603.g006
Inhibition of the Esterase-Like Activity of HSA and prostaglandin binding, thus accelerating the clearance of prostaglandins, which represents an additional mechanism of the aspirin anti-inflammatory action [29] . Kinetics for the hydrolysis of NphOHe and NphODe by HSA are pH dependent, reflecting the acidic pK a shift of an apparently single ionizing group of HSA upon substrate binding. This could reflect the reduced solvent accessibility of the Tyr411 residue, representing the primary esterase site of HSA (see [9, [12] [13] [14] ), although long range effects could not be ruled out. The Tyr411 catalytic residue is located in the FA3-FA4 cleft, which is made by an apolar region forming the FA3 site and a polar patch contributing the FA4 site. The polar patch is centered on the Tyr411 side chain and includes Arg410, Lys414, and Ser489 residues [8, 30, 31] . The inspection of the three-dimensional structure of the ligand-free HSA [32] and of the molecular model of the HSA:4-nitrophenyl propionate complex [9] suggests that the observed pH effects (Fig. 3) could reflect the acidic pK a shift of the Tyr411 residue upon substrate binding. This would render more stable the negative charge on the phenoxyl O atom of Tyr411, which appears to be hydrogen bonded to the carbonyl O atom of 4-nitrophenyl propionate [9] , potentiating its nucleophilic role as an electron donor in the pseudo-esterase activity of HSA. Of note, the acidic shift of the pK a value of the ionizing group affecting catalysis from 8.9±0.1 in ligand free-HSA to 8.1±0.2, 7.6±0.2, 7.0±0.2, and 6.8±0.2 in the HSA:NphOAc, HSA:NphOHe HSA: NphODe, and HSA:NphOMy complexes (see Table 2 ), respectively, depends on the length of the fatty acid tail. Therefore, it appears as the increase of the FA tail length brings about the progressive reduction of the water solvent accessibility, thus enhancing the hydrophobicity of the catalytic site and leading to a decreased pK a of the ionizing group modulating the catalysis. Of note, the pH dependence of the Tyr411-associated esterase activity parallels the pH-dependent neutral-to-basic allosteric transition of HSA [3] .
Diazepam, diflunisal, ibuprofen, 3-indoxyl-sulfate, and/or propofol inhibit competitively the hydrolysis of NphOAc [13] , NphOHe (present study), NphODe (present study), and NphOMy (see [12] and present study) (Fig. 5 ) by impairing the accessibility of 4-nitroplenyl esters to the Tyr411 catalytic center. In particular, diazepam, diflunisal, ibuprofen, and 3-indoxyl-sulfate bind to the center of the FA3-FA4 cleft, with one O atom being hydrogen bonded to the Tyr411 OH group (Fig. 6 ). On the other hand, propofol binds to the apolar region of the FA3-FA4 cleft with the phenolic OH group making a hydrogen bond with the carbonyl O atom of Leu430. Moreover, the aromatic ring of the propofol is sandwiched between the Asn391 and Leu453 side chains. Furthermore, one of the two isopropyl groups of propofol makes several apolar contacts at one end of the pocket, whereas the other is solvent exposed at the cleft entrance making close contacts with Asn391, Leu407, Arg410, and Tyr411 (Fig. 6 ) [8, 30, 31] .
The different K I values for diazepam, diflunisal, ibuprofen, 3-indoxyl-sulfate, and propofol binding to HSA (Fig. 5 ) agree with the selectivity of the FA3-FA4 cleft of HSA, which can be ascribed to the presence of a basic polar patch located at one end of the apolar FA3-FA4 cleft. Remarkably, diazepam, diflunisal, ibuprofen, and 3-indoxyl-sulfate are oriented with at least one O atom in the vicinity of the polar patch. On the other hand, the single polar hydroxyl group in the center of propofol does not interact with the polar patch of the FA3-FA4 cleft. Moreover, the FA3-FA4 cleft appears to adopt different ligand-dependent shapes, thus paying different free energy contributions for structural rearrangements [8] .
Conclusion
Due to the relevant physiological role of HSA in human plasma, in vivo implications can be argued from the present results. Accounting for the plasma levels of HSA (i.e., [HSA] = 7.5×10 -4 M) [2] as well as of diflunisal, ibuprofen, and 3-indoxyl-sulfate plasma levels (i.e., [ligand] ; see below) and K I values for ligand binding (Fig. 4 and Fig. 5 ), the molar fraction (i.e., Y) of diazepam, diflunisal, ibuprofen, 3-indoxyl-sulfate, and propofol bound to plasmatic HSA was calculated according to equation (11) [33] :
The following therapeutic plasma levels of the drugs investigated are commonly reported at steady-state: (i) 0.3-0.4 μg/mL (i.e., 1.1×10 -6 [43, 44] .
Since the plasma levels of diflunisal, ibuprofen, and 3-indoxyl-sulfate (see above) are higher than values of K I for ligand binding to HSA by about 100 folds (see Fig. 4 and Fig. 5 ), the molar fraction of diflunisal, ibuprofen, and 3-indoxyl-sulfate bound to HSA is higher than 0.9, according to equation, (11) . Although the commonly reported diazepam and propofol plasma levels (see above) are lower than the corresponding values of K I for drug binding to HSA (see Fig. 4 and Fig. 5 ) by about 5 and 100 folds, respectively, the plasma HSA concentration (see above) is higher than K I for by about 70 and 2 folds, respectively. According to equation (11) , the molar fraction of diazepam and propofol bound to HSA in plasma is higher than 0.9 and 0.5, respectively.
As a whole, data here reported highlight the role of drugs diazepam, diflunisal, ibuprofen, and propofol as well as of the uremic toxin 3-indoxyl-sulfate to inhibit competitively the pseudo-esterase activity of HSA, Tyr411 representing the nucleophile. This aspect is appropriate since HSA acylation appears to modulate ligand binding [28, 29] and the detoxification of several compounds [2, 3] . Last, HSA not only acts as a carrier and as a detoxifier but also displays transient drug-and toxin-based properties, representing a case for "chronosteric effects" [45] . This opens the scenario toward the possibility of a drug-and toxin-dependent multiplicity of roles for HSA. 
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